CASTLE BIOSCIENCES INC (CSTL)
Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, Decision Dx DiffDx-Melanoma, Decis
Office
CS Hotline: +852 3018 4526
Trading days: 24 hours
Non-trading days: 9:00-18:00
Email: cs@usmarthk.com
Address: 26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong
WhatsApp: +852 5989 2641
Physical Store
